Arthroscopy Devices Market Research Report and Outlook by 2028

The arthroscopy devices market is anticipated to grow significantly, reaching an estimated US$ 9,853.88 million by 2028, up from US$ 5,725.24 million in 2021. This growth represents a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028.

Several key factors are propelling the expansion of the arthroscopy devices market. The increasing incidence of musculoskeletal disorders, a rise in sports-related injuries necessitating arthroscopic procedures to avert total joint replacements, and an aging population are all contributing to market growth. Conversely, the high costs associated with arthroscopy devices pose a challenge to the market's advancement.

Arthroscopy is a minimally invasive surgical procedure used for diagnosing and treating joint issues. During this procedure, a surgeon inserts a slender tube equipped with a fiber-optic video camera, known as an arthroscope, through a small incision, roughly the size of a buttonhole. This device enables healthcare professionals to visualize the interior of joints such as the knee, hip, spine, shoulder, and elbow, facilitating inspection, diagnosis, and therapeutic interventions. Arthroscopy devices are instrumental in examining conditions like osteoarthritis, rheumatoid arthritis, tendinitis, and bone tumors affecting the joints.

Musculoskeletal disorders (MSDs) rank among the most prevalent health issues globally. According to the World Health Organization (WHO), as of February 2021, approximately 1.71 billion people worldwide are affected by musculoskeletal conditions, with lower back pain being particularly widespread, impacting 568 million individuals. This condition is the leading cause of disability in 160 countries, with musculoskeletal disorders being the primary contributor to disability worldwide. These disorders significantly hinder mobility and dexterity, often leading to early retirement, reduced quality of life, and decreased societal participation. The number of individuals suffering from musculoskeletal conditions is on the rise, a trend expected to persist in the coming decades.

Furthermore, the WHO reports that high-income nations are the most affected, with 441 million individuals impacted, followed by the WHO Western Pacific Region with 427 million, and South-East Asia with 369 million. Musculoskeletal diseases are also the leading cause of years lived with disability (YLDs) globally, accounting for approximately 149 million YLDs, or 17% of all YLDs. Low back pain is identified as the foremost cause of musculoskeletal disorders, with fractures affecting 436 million people, osteoarthritis impacting 343 million, and other injuries, neck pain, amputations, and rheumatoid arthritis contributing significantly to the overall burden of these diseases.

For patients experiencing chronic joint pain and dysfunction, surgical arthroscopy is a well-established treatment option. Compared to traditional open joint surgeries, arthroscopy is less invasive, leading to improved patient outcomes regarding symptom relief, shorter hospital stays, better structural recovery, and favorable long-term results. Consequently, the rising prevalence of conditions such as osteoarthritis and rheumatoid arthritis is expected to further stimulate market growth during the forecast period.

The arthroscopy devices market is categorized by product type into several segments, including arthroscopes, arthroscopic implants, fluid management systems, radiofrequency systems, visualization systems, powered shaver systems, and other arthroscopic tools. In 2021, the arthroscopes segment dominated the market and is projected to exhibit the fastest CAGR of 9.1% throughout the forecast period.

In terms of application, the arthroscopy devices market is divided into segments such as knee arthroscopy, hip arthroscopy, spine arthroscopy, foot and ankle arthroscopy, shoulder and elbow arthroscopy, and others. The hip arthroscopy segment held the largest market share in 2021 and is expected to achieve the highest CAGR of 8.9% from 2021 to 2028.

Leading companies in the arthroscopy devices market include Arthrex, Inc., CONMED Corporation, Johnson and Johnson Services, Inc., KARL STORZ SE & Co. KG, Medtronic, Richard Wolf GmbH, Smith & Nephew, Stryker Corporation, Zimmer Biomet, and NuVasive, Inc..

Key secondary sources utilized in the preparation of the report on the arthroscopy devices market include the National Federation of State High School Associations (NFHS), Canadian Institute of Health Information (CIHI), Organisation for Economic Co-operation and Development (OECD), International Osteoporosis Foundation (IOF), Australian Orthopedic Association National Joint Replacement Registry (AOANJRR), Australian Bureau of Statistics (ABS), and the World Health Organization (WHO).